Low level testosterone measurement
With a simple blood test, the ARCHITECT 2nd Generation Testosterone Assay can accurately measure the wide range of testosterone levels seen in a number of different patient populations and clinical settings. Testosterone assays play an important role in the diagnosis and management of many medical conditions in men, women, and children. However, many currently available testosterone assays are not sensitive enough to measure low levels of testosterone. This system allows reliable and reproducible assessment of testosterone in patients suspected to have low circulating testosterone levels, attributes which can be beneficial for patients and their doctors as well as for the laboratory. The device provides consistent and accurate testing of testosterone levels across a wide range of concentrations and fulfils the need for a rapid, sensitive and fully automated testosterone assay. The assay is a chemiluminescent microparticle immunoassay for the quantitative determination of testosterone in human serum and plasma. Measurements of testosterone are used in the diagnosis and treatment of disorders involving 1) the male sex hormones (androgens) including primary and secondary hypogonadism, delayed or precocious puberty, and impotence in males; and 2) in females, hirsutism (excessive hair) and virilization (masculization) due to tumours, polycystic ovaries, and androgenital syndromes. Health care providers can now confidently measure testosterone levels and use this information to improve treatment decisions for their patients.